Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Cervical Neoplasms 17Uterine Cervical Dysplasia 10Papillomavirus Infections 6Precancerous Conditions 3Neoplasms 3Squamous Intraepithelial Lesions 2Genital Diseases 2Atypical Squamous Cells of the Cervix 2Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Neoplasms 1Uterine Diseases 1Uterine Cervical Diseases 1Urogenital Neoplasms 1Urogenital Diseases 1Sexually Transmitted Diseases, Viral 1Sexually Transmitted Diseases 1Neoplasms by Site 1HIV Infections 1Genital Neoplasms, Female 1Genital Diseases, Female 1Female Urogenital Diseases and Pregnancy Complications 1Cervical Intraepithelial Neoplasia Grade 1 (CIN 1) 1Adenocarcinoma in Situ 1

Interventions

Electrocoagulation 1Community Health Workers 1Colposcopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Sexually Transmitted Diseases × Colposcopy × Clear all
NCT07281599 2026-02-02

EQUIP

Qurasense

Phase NA Recruiting
450 enrolled
Gynecologic

Genital Diseases, Uterine Cervical Neoplasms, Sexually Transmitted Diseases, Sexually Transmitted Diseases, Viral, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡